Timothy Nj Bullock

30PUBLICATIONS
97CO-AUTHORS
Gene and molecular therapyMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 24, 2026
Immediate Growth Control in Response to Boiling Histotripsy is Prognostic for Intratumoral Immune Activation.

|Jun 11, 2026
Myeloid Cell Targeting Strategies Show Limited Durable Activity in the Breast Cancer Tumor Microenvironment and Do Not Enhance the Activity of Thermally Ablative Focused Ultrasound.

|May 29, 2026
UBA1-CDK16: A female-specific chimeric RNA emerging through evolution and involved in immune regulation.

|Apr 10, 2026
Randomized Phase I/II Clinical Trial of a Melanoma Helper Peptide Vaccine with or without Systemic Agonistic Anti-CD27 Antibody (Varlilumab).

Emily K Ninmer, Gina R Petroni, Elizabeth Gaughan

|Mar 03, 2026
Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC).

Emily K Ninmer, Gina R Petroni, Brian R Gastman

|Feb 10, 2026
The influence of VEGFR-2 blockade and focused ultrasound blood-brain barrier opening on the glioma-immune landscape.

Katherine M Nowak, Matthew R Hoch, Victoria R Breza

Pageof 5

Frequent Collaborators

6 joint publications

Richard J Price

5 joint publications

Craig L Slingluff

3 joint publications

Lydia E Kitelinger

3 joint publications

Michael G Brown